Showing results (861-870 of 930) with videos related to
Sort By:
Pageof 93
Cancers|October 13, 2021
Immune Markers and Tumor-Related Processes Predict Neoadjuvant Therapy Response in the WSG-ADAPT HER2-Positive/Hormone Receptor-Positive Trial in Early Breast CancerNadia Harbeck, Raquel von Schumann, Ronald Ernest Kates, et al.Infection|April 15, 2025
Identifying patients at high risk for antibiotic treatment following hospital admission: a predictive score to improve antimicrobial stewardship measuresMoritz Beck, Carolin Koll, Uga Dumpis, et al.Biomaterials|December 8, 2017
Strontium and bisphosphonate coated iron foam scaffolds for osteoporotic fracture defect healingSeemun Ray, Ulrich Thormann, Marlen Eichelroth, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2018
Contribution of Adrenal Glands to Intratumor Androgens and Growth of Castration-Resistant Prostate CancerElahe A Mostaghel, Ailin Zhang, Susana Hernandez, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2025
Multiomic Factor Analysis for Pathologic Complete Response after Pembrolizumab + Trastuzumab + Pertuzumab in HER2-Enriched Early Breast Cancer: WSG-Keyriched-1 TrialMonika Graeser, Oleg Gluz, Peter Schmid, et al.Pilot and Feasibility Studies|September 19, 2022
Functional, imaging, and respiratory evaluation (FIRE) of patients post-hospitalization for COVID-19: protocol for a pilot observational studyKirby P Mayer, Jessica A Palakshappa, Ithan Daniel Peltan, et al.Critical Care Medicine|July 17, 2015
Lung-Protective Ventilation With Low Tidal Volumes and the Occurrence of Pulmonary Complications in Patients Without Acute Respiratory Distress Syndrome: A Systematic Review and Individual Patient Data AnalysisAry Serpa Neto, Fabienne D Simonis, Carmen S V Barbas, et al.Infection|March 11, 2025
Clinical heterogeneity and treatment outcomes of extrapulmonary tuberculosis in a low-incidence setting: insights from a prospective cohort studyAngela Klingmüller, Marie Feldmann, Samuel Rohr, et al.The Journal of Antimicrobial Chemotherapy|June 21, 2019
Controlling intestinal colonization of high-risk haematology patients with ESBL-producing Enterobacteriaceae: a randomized, placebo-controlled, multicentre, Phase II trial (CLEAR)Vassiliki Dimitriou, Lena M Biehl, Axel Hamprecht, et al.Journal for Immunotherapy of Cancer|November 17, 2020
Differential effect on different immune subsets of neoadjuvant chemotherapy in patients with TNBCChiara Massa, Thomas Karn, Carsten Denkert, et al.Pageof 93